Saturday, 04 September 2010
Bigger size Smaller size Subscribe RSS
You are here: Sitemap
Library Recommendation
Forthcoming issue

Sitemap articles

Cardiology

Beta-blockers in heart failure: the state of the art
Beta-blockers in heart failure: the state of the art
Alexander Lyon - MA, BM, BCh, MRCP     Sian Harding - Bsc, PhD     Philip A. Poole-Wilson - MD, FRCP, FACC, FESC, FMedSci    
Cardiovascular complications of obesity and weight loss: pathogenesis and clinical recognition
Cardiovascular complications of obesity and weight loss: pathogenesis and clinical recognition
Paul Poirier - MD, PhD, FRCPC    
Heart failure: from bench to bedside
Heart failure: from bench to the bedside
Sergio Dalla Volta - MD, PhD    
The phenomenon of "resistance" to antiplatelet drugs
The phenomenon of resistance to antiplatelet drugs
Carlo Patrono - MD     Bianca Rocca - MD, PhD    
Angiotensin AT1 receptor antagonists in patients at high risk for cardiovascular events: the state of the art
Angiotensin AT1 receptor antagonists in patients at high risk for cardiovascular events: the state of the art
Thomas Unger - MD     Jan H. Schefe     
Prevention of cardiovascular diseases in asymptomatic apparently healthy people
Prevention of cardiovascular diseases in asymptomatic, apparently healthy people
Guy De Backer - MD, PhD    
Management and treatment of angina pectoris: new evidence and new ideas with a focus on the results of the ACTION trial
Management and treatment of angina pectoris: New evidence and new ideas with a focus on the results of the ACTION trial
Philip A. Poole-Wilson - MD, FRCP, FACC, FESC, FMedSci    
Current concepts for achieving blood pressure goals: usefulness of dihydropyridines with a focus on barnidipine
Current concepts for achieving blood pressure goals: usefulness of dihydropyridines, with a focus on barnidipine
Julian Segura - MD     Luis M. Ruilope - MD    
The treatment of hypertension and the prevention of organ damage
The treatment of hypertension and the prevention of organ damage
Antonio Coca - MD, PhD, FRCP     Cristina Sierra - MD, PhD    
Clinical pharmacology of beta-blockers in cardiology: trial results and clinical applications
Clinical pharmacology of beta-blockers in cardiology: trial results and clinical applications
Philippe Lechat - MD, PhD    
Fish, long-chain omega-3 polyunsaturated fatty acids, and cardiovascular disease
Fish, long-chain omega-3 polyunsaturated fatty acids, and cardiovascular disease
Claudio Galli - MD     Patrizia T. Risé - PhD     Cesare R. Sirtori - MD    
Hypertension and hypercholesterolemia: from theory to cardiovascular disease risk prevention
Hypertension and hypercholesterolemia: from theory to cardiovascular disease risk prevention
Claudio Borghi - MD     Arrigo F.G. Cicero - MD    
Acute coronary syndromes: the role of statins
Acute coronary syndromes: the role of statins
Amit Kumar - MD     Christopher P. Cannon - MD    
Uric acid and cardiovascular diseases
Hyperuricemia and vascular damage
Michael H. Alderman - MD    
Uric acid disorders and cardiovascular diseases: current evidence for treatment and future questions
Claudio Borghi - MD    
The vascular endothelium in hypertension: target and promoter?
The vascular endothelium in hypertension: target and promoter?
Isabella Sudano - MD, PhD     Andreas J. Flammer - MD     Jan Steffel - MD     Georg Noll - MD     Thomas F. Lüscher - MD, FRCP    
Beta-blockers in noncardiac surgery: do they really work?
Beta-blockers in noncardiac surgery: do they really work?
Alberto Margonato - MD, FESC     Stefano Gerosa - MD    
Hypertension and hypercholesterolemia: from theory to cardiovascular disease risk prevention. Second edition
Hypertension and hypercholesterolemia: from theory to cardiovascular disease risk prevention. Second edition
Claudio Borghi - MD     Arrigo F.G. Cicero - MD    
Novel oral antithrombotic and antiarrhythmic approaches for atrial fibrillation
New oral antithrombotic strategies
Christian T. Ruff - MD     Robert P. Giugliano - MD, SM    
Novel antiarrhythmic approaches to treatment of atrial fibrillation
Stefan H. Hohnloser - MD    
New frontiers of aspirin therapy
Does low-dose aspirin prevent cardiovascular events during influenza outbreaks? Review of the evidence
Alastair J.S. Webb - BA, BMBCh, MRCP     Peter M. Rothwell - MD, PhD, FRCP, FMedSci    
Benefit of low-dose aspirin in patients with hypertension
Farzin Beygui - MD, PhD     Gilles Montalescot - MD, PhD    
Cardiovascular benefits of aspirin in patients with neurological disorders
Ralph Weber - MD     Hans-Christoph Diener - MD, PhD     Kolja Busch - MD    
Oral antiplatelet agents: new insights in managing patients with acute coronary syndromes
Oral antiplatelet agents: new insights in managing patients with acute coronary syndromes
Marc P. Bonaca - MD     Robert P. Giugliano - MD, SM    

Cardiometabolic Disorders

Metabolic effects of telmisartan
Metabolic effects of the ARB telmisartan: potential mechanisms
Ulrich Kintscher - MD    
Antidiabetogenic effects of telmisartan: evidence from clinical trials
Alejandro de la Sierra - MD, PhD    
DPP-4, diabetes, and the heart: issues and opportunities
DPP-4 inhibitors in the treatment of type 2 diabetes
Matthew P. Gilbert - DO, MPH     Richard E. Pratley - MD    
Potential effects of DPP-4 inhibitors on cardiovascular disease
Vivian A. Fonseca - MD, FRCP    

Neurology and Psychiatry

Vascular dementia
Vascular dementia: clinical presentation and symptomatic treatment
Rita Moretti - MD     Paola Torre - MD    
Management of risk factors in vascular dementia: hypertension
Massimo Volpe - MD, FAHA, FESC     Angelo Scuteri - MD, PhD    
Antipsychotic prescribing in older people and cerebrovascular risks
Stephen Curran - MRCPsych, PhD     Andrew Byrne - MRCPsych     Lance Middleton - MRCPsych    
Depression in old age
Geriatric depression
Vassilios Latoussakis - MD     Sibel Klimstra - MD     George S. Alexopoulos - MD    
The efficacy of selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs) in older people: the state of the art
Cornelius Katona - MD, FRC Psychiatry     Amber Selwood - MBChB, MSc, MRC Psychiatry    
Role of antiplatelet agents and anticoagulants in a neurological population
The role of anticoagulants in a neurological population
Brett L. Cucchiara - MD    
The role of antiplatelet agents in stroke prevention
Marco N. Cattaneo - MD    
Role of anticoagulants in a neurological population: primary and secondary prevention of cardioembolic stroke
Umberto Cucchini - MD     Vittorio Pengo - PhD    
Memantine: potential and demonstrated effects of a new drug
Memantine: potential and demonstrated effects of a new drug
Rita Moretti - MD     Paola Torre - MD    
Parkinson/Dementia complex and Lewy body dementia: perspectives and treatments
Cognitive and behavioral changes in Parkinson complex
Amos D. Korczyn - MD, MSc    
Dementia with Lewy bodies and Parkinson disease dementia
Clive G. Ballard - MB, ChB, MRCPsych, MMedSci, MD     Katja Kossakowski - MRes, BSc     Nicholas MacInnes - PhD     Dag Aarsland - MD, PhD    
Acute ischemic stroke management: the state of the art
Acute ischemic stroke management: the state of the art
Richard K. Chan - MBBS(S’pore), FRCP(Edin), FRCPC     Patrick Pullicino - MD, PhD    
Statins, lipid lowering and stroke
Statins, lipid lowering and stroke
Pierre Amarenco - MD    

Respiratory Medicine

Chronic obstructive pulmonary disease: the exacerbation
Acute exacerbations of chronic bronchitis and COPD: definition and impact
Fernando J. Martinez - MD, MS    
Management of acute exacerbations of chronic bronchitis and COPD: microbiology, treatment, and prevention
Francesco Blasi - MD, PhD    
Future lines of research in exacerbations of chronic bronchitis and COPD: new clinical trials
Marc Miravitlles - MD    
Effects of antibiotics on exacerbation-free intervals in patients with chronic bronchitis and chronic obstructive pulmonary disease
Impact of exacerbations on patients with COPD
Antonio Anzueto - MD    
Importance of bacterial eradication in exacerbations of chronic obstructive pulmonary disease
Marc Miravitlles - MD    
Using antibiotics to delay exacerbations of chronic obstructive pulmonary disease
Robert Wilson - MD, FRCP    
Chronic obstructive pulmonary disease: definition, epidemiology and diagnostic procedures
Chronic obstructive pulmonary disease: definition, guidelines, and severity staging
Maria Montes de Oca - PhD    
Epidemiology of chronic obstructive pulmonary disease worldwide
Joan B. Soriano - MD, PhD    
Imaging in chronic obstructive pulmonary disease
Saher Burhan Shaker - MD, PhD    
Early diagnosis of chronic obstructive pulmonary disease: the use of spirometry for case detection in primary care
Jan Zieliński - MD, PhD    
Chronic obstructive pulmonary disease: etiology and natural history
Other causes of chronic obstructive pulmonary disease: exposure to biofuel smoke
Alejandra Ramírez-Venegas - MD     Rogelio Perez-Padilla - MD     Rosa María Rivera - MD     Raul H. Sansores - MD    
Nicotine addiction and smoking cessation in chronic obstructive pulmonary disease patients
Dorota M. Górecka - MD, PhD    
Natural course of chronic obstructive pulmonary disease
Niels Seersholm - MD, PhD    
Chronic obstructive pulmonary disease: the treatment (Part One)
Guidelines for the treatment of COPD
Javier de Miguel Díez - MD     Myriam Calle Rubio - MD     Juan Luis Rodríguez Hermosa - MD     José L. Álvarez-Sala - MD, PhD    
Tiotropium bromide
Nicholas J. Gross - MD, PhD    
Pulmonary rehabilitation
José R. Jardim - MD     Oliver A. Nascimento - MD    
Chronic obstructive pulmonary disease: treatment (Part Two)
Inhaled corticosteroids in the treatment of bronchial and systemic inflammation
Don D. Sin - MD, MPH     Shu-Fan Paul Man - MD    
Combination therapy: long-acting β2-agonists and inhaled corticosteroids
Mario Cazzola - MD    
Mucolytics in the treatment of chronic bronchitis and COPD
Peter N. Black - MB ChB, FRACP    
New treatments for COPD
Alice M. Wood - MBChB     Robert A. Stockley - MD, DSc, FRCP    
Modifying the clinical course of COPD
Modifying the clinical course of COPD
Antonio Anzueto - MD     Marc Miravitlles - MD    
New advances in smoking cessation
The epidemiology of smoking: a growing concern
Lion Shahab - PhD    
Smoking cessation in patients with chronic obstructive pulmonary disease and lung cancer
Carlos A. Jiménez-Ruiz - MD, PhD    
Pharmacologic approaches to smoking cessation
Michael A. Chandler - MD     Stephen I. Rennard - MD    
Sleep apnea: a new epidemic
Prevalence of sleep apnea in adults
Carlos Zamarrón - MD    
Screening adults for obstructive sleep apnea
Hisham Elsaid - MD     Frances Chung - FRCPC    
Sleep-disordered breathing and cardiovascular disease
Kannan Ramar - MD     Sean M. Caples - DO    
Advances in the treatment of sleep apnea
Josep M. Montserrat - MD     Francisco Capote - MD    
Community-acquired pneumonia (Part One)
Etiology and epidemiology of community-acquired pneumonia
Sebastian R. Ott - MD    
The economic impact of community-acquired pneumonia
Maria Bartolomé Regué - MD     Jordi Almirall - MD, PhD    
Critical review of guidelines for community-acquired pneumonia in immunocompetent adults
Sergio Carbonara - MD    
Treatment failure in community-acquired pneumonia: clinical relevance and risk factors
Rosario Menéndez - MD, PhD     Antoni Torres - MD    
The clinical course of COPD: earlier intervention
The natural history of chronic obstructive pulmonary disease
David M. Mannino - MD     Naomi L. Hudson - MPH    
The importance of early diagnosis in chronic obstructive pulmonary disease
Gary T. Ferguson - MD    
Prevention of exacerbations and the impact on the clinical course of chronic obstructive pulmonary disease
Marc Miravitlles - MD    
Importance of sustained bronchodilatation
Pierluigi Paggiaro - MD     Francesco Costa - MD     Barbara Vagaggini - MD    
Optimizing bronchodilation in chronic obstructive pulmonary disease: is it possible?
Indacaterol, a new ultra-long-acting bronchodilator for chronic obstructive pulmonary disease
Adolfo Baloira Villar - MD    
How to obtain maximal bronchodilation in chronic obstructive pulmonary disease
Mario Cazzola - MD    
Clinical benefits of maximal bronchodilation in chronic obstructive pulmonary disease (Part I)
Denis E. O’Donnell - MD, FRCP (I), FRCP ©     Josuel Ora - MD     Pierantonio Laveneziana - MD    
Clinical benefits of maximal bronchodilation in chronic obstructive pulmonary disease (Part II)
Juan José Soler-Cataluña - MD     Miguel Ángel Martínez-García - MD    
Influenza A (H1N1): the disease, its treatment and prevention
The epidemiology of influenza viruses in humans
Pieter L.A. Fraaij - MD, PhD     Albert D.M.E. Osterhaus - MD    
Clinical manifestations of influenza A (H1N1)
Alejandra Ramírez Venegas - MD     Oliver Pérez Bautista - MD     Raúl H. Sansores - MD    
Influenza A. Prevention and treatment
Gernot Rohde - MD    

Hypertension

Renal protection with telmisartan: a key target when managing hypertension and diabetes
Renal protection with telmisartan: a key target when managing hypertension and diabetes
Massimo Volpe - MD, FAHA, FESC     Giuliano Tocci - MD    
Insulin resistance and hypertension: the link
Insulin resistance and hypertension: the link
Carmine Morisco - MD, PhD     Bruno Trimarco - MD    
Hypertension and the kidney
Hypertension and the kidney
José A. García-Donaire - MD     Julián Segura - MD     Luis M. Ruilope - MD    
Role of the renin-angiotensin system in hypertension
Role of the renin-angiotensin system in hypertension
Kai Kappert - MD     Thomas Unger - MD, PhD    
Efficacy and tolerability of valsartan in cardiovascular disease
Efficacy and tolerability of valsartan in cardiovascular disease
Claudio Borghi - MD    
Fixed-dose combination therapy to overcome unmet needs in hypertension: focus on olmesartan medoxomil/amlodipine
Fixed-dose combination therapy to overcome unmet needs in hypertension: focus on olmesartan medoxomil/amlodipine
Massimo Volpe - MD, FAHA, FESC    
New options for therapeutic management of patients with cardiovascular disease. A closer look at clinical trials with telmisartan
New options for therapeutic management of patients with cardiovascular disease. A closer look at clinical trials with telmisartan
Massimo Volpe - MD, FAHA, FESC    
New therapeutic progress in cardiorenal protection of the hypertensive patient with a focus on olmesartan
New therapeutic progress in cardiorenal protection of the hypertensive patient with a focus on olmesartan
Vivencio Barrios - MD, PhD, FESC     Carlos Escobar - MD, PhD     Rocio Echarri - MD     Fernando de Alvaro - MD, PhD    

Oncology

Management of cancer pain
Pharmacological management of cancer pain
Rebecca Solomon - MBBS, MRCP     Nathan I. Cherny - MBBS, FRACP    
Nonpharmacological treatment of cancer pain: tools for the practitioner
Lynette A. Menefee Pujol - PhD     Dajie Wang - MD    
Melanoma
Novel targets in melanoma: stopping the signals that make tumors go
Michael P. O'Connell - PhD     Ashani T. Weeraratna - PhD    
Immunotherapy of melanoma
Brendan D. Curti - MD     Walter J. Urba - MD, PhD    
Cervical cancer
Human papillomavirus vaccine for cervical cancer prevention
Richard B. S. Roden - PhD     Archana Monie      T.-C. Wu - MD, PhD    
Clinical efficacy and use of Gardasil®
Dan L. Longo - MD    
Management of cervical cancer
Jonathan S. Berek - MD, MMS     Nita K. Lee - MD, MPH    
Renal cancer
The role of sunitinib in metastatic renal cell carcinoma
Ali-Reza Golshayan - MD     Ronald M. Bukowski - MD    
The role of sorafenib in the management of renal cell carcinoma
James M.G. Larkin - PhD, MRCP     Simon Chowdhury - MA, MRCP, PhD     Martin E. Gore - PhD, FRCP    
New agents in the treatment of advanced renal cell cancer: making a guided choice
Guru Sonpavde - MD     Thomas E. Hutson - DO, PharmD, FACP     Cora N. Sternberg - MD, FACP    
Hepatocellular carcinoma
Management of liver cirrhosis and prognostic classification of hepatocellular carcinoma
Luigi Bolondi - MD     Alice Gianstefani - MD    
Locoregional and systemic treatments for patients with hepatocellular carcinoma
Bruno Daniele - MD, PhD     Massimo Di Maio - MD    
Colorectal cancer
Adjuvant treatment in colorectal cancer
Yu Jo Chua - FRACP     David Cunningham - FRCP    
Medical treatment and management of advanced unresectable colorectal cancer
Aimery de Gramont - MD     Christophe Tournigand - MD, PhD     Christophe Louvet - MD, PhD     Frédérique Maindrault-Goebel - MD     Thierry André - MD     Annette K. Larsen - DVM, PhD    
Molecular and clinical heterogeneity in breast cancer
Treatment of hormone receptor negative breast cancer
Eleni Andreopoulou - MD     Gabriel N. Hortobagyi - MD, FACP    
Use of gene expression profiling to identify breast cancer patients at an increased risk of metastasis
Otto Metzger-Filho - MD     Philippe Bedard - MD     Michail Ignatiadis - MD, PhD     Christos Sotiriou - MD, PhD    

Viral Hepatitis

Difficult-to-treat patients with chronic hepatitis C (Part One)
HIV and hepatitis C virus coinfection
Vincent Soriano - MD, PhD     Pablo Barreiro - MD, PhD     Luz Martin-Carbonero - MD, PhD     Marina Núñez - MD, PhD    
Hepatitis C and metabolism
Hepatitis C and diabetes
Elisabetta Bugianesi - MD, PhD    
Hepatitis C and overweight
Shivakumar Chitturi - MD, MRCP (UK)     Jacob George - MBBS, PhD, FRACP    
Hepatitis C and fatty liver
Luigi Elio Adinolfi - MD    
Infection and atherosclerosis: what evidence is there for a role for hepatitis C virus?
Cristina Vassalle - PhD    
Difficult-to-treat patients with chronic hepatitis C (Part Two)
Ethnic differences in response to antiviral treatment
Elliott D. Kozin - BA     K. Rajender Reddy - MD    
Treatment of chronic hepatitis C in patients with cirrhosis
Gregory T. Everson - MD    
Responders-relapsers and nonresponders to previous antiviral therapy
Nevin Yilmaz - MD     Mitchell L. Shiffman - MD    
Antiviral therapy in chronic hepatitis C: a critical approach to evidence
Calogero Cammà - MD     Antonio Craxì - MD    
Treatment of chronic hepatitis B: an update
Diagnostic tools in hepatitis B
Stéphane Chevaliez - PharmD, PhD     Jean-Michel Pawlotsky - MD, PhD    
Hepatitis B virus kinetics and modeling of virus infection dynamics
Piero Colombatto - MD     Luigi Civitano - PhD     Ferruccio Bonino - MD     Maurizia Rossana Brunetto - MD    
Pegylated interferon alpha for chronic hepatitis B-alone or in combination with lamivudine
Erik H.C.J. Buster - MD     Martijn J. ter Borg - MD     Harry L.A. Janssen - MD, PhD    
Chronic hepatitis B: current treatment and future directions
Tarik Asselah - MD, PhD     Nathalie Boyer - MD     Patrick Marcellin - PhD    
Vaccination against hepatitis B and C: the state of the art
Vaccination against hepatitis B: a historical overview
Alessandro R. Zanetti - PhD     Pierre Van Damme - MD, PhD     Daniel Shouval - MD    
Why is it so difficult to find a vaccine against hepatitis C?
Gabriele Missale - MD    
Hepatitis C transmission: current issues (Part One)
Hepatitis C: iatrogenic transmission, past issues and current challenges
Daniel Lavanchy - MD, MHEM    
Sexual transmission of hepatitis C: controversies and facts
Virginie Masserey Spicher - MD    
Strategies to control hepatitis C infection among injection drug users
Srinivas Cheruvu - MD     Ann B. Beeder - MD     Michael R. Carden - MS     Brian R. Edlin - MD     Andrew H. Talal - MD, MPH    
Health care workers: are they at risk for HCV infection?
Piero L. Almasio - MD     Tommaso Stroffolini - MD    
Hepatitis A virus: still a hot topic?
Hepatitis A virology
Verena Gauss-Müller - PhD    
HAV: general epidemiology, routes of transmission and groups at risk
Paolo Bonanni - MD     Sara Boccalini - MSc     Angela Bechini - MSc, PhD    
HAV: epidemiology in the Southern Hemisphere
Hugo Cheinquer - MD, PhD     Christina H. Targa Ferreira - MD, PhD     Nelson Cheinquer - MD    
Clinical features of hepatitis A
Paolo Bonanni - MD     Sara Boccalini - MSc     Angela Bechini - MSc, PhD    
Vaccination against hepatitis A: a review of the evidence
Paolo Bonanni - MD     Sara Boccalini - MSc     Angela Bechini - MSc, PhD    
New antivirals in hepatitis C
New inhibitors of the HCV life cycle
Roniel Cabrera - MD, MS     David R. Nelson - MD, PhD    
New immunomodulators in the treatment of chronic hepatitis C: hopes and concerns
Yves Horsmans - MD, PhD    
Antifibrosing agents
Fabio Marra - MD, PhD    
Management of side effects of interferon alfa and ribavirin-based treatment of chronic hepatitis C
Bone marrow toxicity and use of growth factors
Stanislas Pol - MD, PhD    
Psychiatric side effects
Martin Schäfer - MD    
Endocrinological side effects
Damien Sène - MD, PhD     Patrice Cacoub - MD, PhD    
Dermatological side effects
Jann Lübbe - MD    
HIV/HCV coinfection: an update
Natural history of HIV/HCV coinfection
Eugenia Vispo - MD     Pablo Barreiro - MD, PhD     Ivana Maida - MD, PhD     Vincent Soriano - MD, PhD    
Treatment of chronic hepatitis C in HIV/HCV-coinfected patients
Massimo Puoti - MD    
Liver transplantation in individuals coinfected with HIV and HCV
Fernando Agüero - MD     Montserrat Laguno - MD     Montse C. Tuset - PharmD     Asunción Moreno - MD, PhD     Antoni Rimola - MD, PhD     José M. Miró - MD, PhD     Hospital Clínic OLT in HIV Working Group     
Hepatitis C transmission: current issues (Part Two)
Mother-to-child hepatitis C virus transmission
Antonella Versace - MD     Stefania Bezzio - MD     Pier-Angelo Tovo - MD    
Transmission of hepatitis C virus in the hemodialysis setting
Fabrizio Fabrizi - MD     Paul Martin - MD    
Controversies in HCV transmission: from tattoos to barbershops
Christine M. Arcari - PhD, MPH     Miriam J. Alter - PhD, MPH    
Liver fibrosis
Fibrosis progression in chronic hepatitis C and B: role of steatosis, metabolic syndrome and environmental factors
Ariane Mallat - MD     Hélène Castel - MD     Daniel Dhumeaux - MD    
Non-invasive assessment of liver fibrosis: a decisional tree
Giada Sebastiani - MD     Alfredo Alberti - MD    
Treatment of liver fibrosis: experience and perspectives
Fabio Marra - MD, PhD    
Intravenous drug users and chronic hepatitis C
Risks and benefits of treating chronic hepatitis C virus infection in injecting drug users
Graham R. Foster - FRCP, PhD    
Improving adherence to antiviral therapy in injecting drug users with chronic hepatitis C virus
Giorgio Barbarini - PhD     Raffaella Brigada - MD    
Is reinfection with hepatitis C virus a major concern after sustained virologic response has beed achieved?
Olav Dalgard - MD, PhD    
Heroin substitution: an exception or an expanded feasibility for providing hepatitis treatment to drug users?
Philip Bruggmann - MD     Adrian Kormann - MD     Daniel Meili - MD    
Hepatitis C virus and metabolism. 2nd edition
Hepatitis C virus and diabetes: epidemiological association and pharmacological intervention
Manuel Romero-Gómez - MD, PhD     Javier García-Samaniego - MD, PhD    
Hepatitis C virus and hepatic insulin resistance: experimental evidence
Elisabetta Bugianesi - MD, PhD    
Impact of lifestyle modification on patients with chronic liver disease
Nathan Johnson - PhD     Alexis B. St. George      Jacob George - MBBS, FRACP, PhD    
Mechanisms of hepatitis C virus-induced fatty liver disease
Amedeo Lonardo - MD     Luigi E. Adinolfi - MD     Paola Loria - MD    
Management of hepatitis B in 2009
Diagnostic assays for hepatitis B virus
Patricia M. Mulrooney-Cousins - PhD     Tomasz I. Michalak - MD, PhD    
The natural history of chronic hepatitis B
Vito Di Marco - MD    
New European guidelines for the treatment of chronic hepatitis B
Mayra J. Sanchez - MD     Maria Buti - MD     Rafael Esteban - MD    
Future antivirals for chronic hepatitis B
Elizabeth A. Kula - FNP     Douglas T. Dieterich - MD    
Recent advances in the treatment of hepatitis C
Treating acute hepatitis C: when and how
Johannes Wiegand - MD    
Re-treatment strategy for chronic hepatitis C patients who have failed prior antiviral therapy
Maria Trapero-Marugán - MD     Ricardo Moreno-Otero - MD    
Optimizing treatment duration in chronic hepatitis C on the basis of virological response
Salvatore Petta - MD     Calogero Cammà - MD    
Clinical management of viral coinfections
Management of patients coinfected with HBV and HCV
Andrej Potthoff - MD     Jerzy Jaroszewicz - MD     Michael P. Manns - MD     Heiner Wedemeyer - MD    
Update on HIV and HCV coinfection
Vincent Soriano - MD, PhD     Eugenia Vispo - MD     Pablo Labarga - MD, PhD     Jose Medrano - MD, PhD     Sonia Albertos - MD     Pablo Barreiro - MD, PhD    
Current therapy of HBV/HIV coinfection
Christoph Boesecke - MD     Jürgen K. Rockstroh - MD    
blank